ZEN Graphene Solutions Ltd (ZTEK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ZEN Graphene Solutions Ltd (ZTEK) has a cash flow conversion efficiency ratio of -0.103x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.21 Million) by net assets ($11.69 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ZEN Graphene Solutions Ltd - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how ZEN Graphene Solutions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ZEN Graphene Solutions Ltd (ZTEK) total liabilities for a breakdown of total debt and financial obligations.
ZEN Graphene Solutions Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ZEN Graphene Solutions Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ImmuCell Corporation
NASDAQ:ICCC
|
-0.040x |
|
PDS Biotechnology Corp
NASDAQ:PDSB
|
-0.400x |
|
Falcon Machine Tools Co Ltd
TWO:4513
|
-0.035x |
|
biote Corp
NASDAQ:BTMD
|
-0.150x |
|
Shinih Enterprise Co Ltd
TW:9944
|
0.008x |
|
Tunas Alfin Tbk
JK:TALF
|
0.034x |
|
Sonel S.A.
WAR:SON
|
-0.006x |
|
IBKS No2 SPAC
KQ:204840
|
-0.014x |
Annual Cash Flow Conversion Efficiency for ZEN Graphene Solutions Ltd (2010–2025)
The table below shows the annual cash flow conversion efficiency of ZEN Graphene Solutions Ltd from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see ZTEK company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | $14.75 Million | $-6.28 Million | -0.426x | -6.72% |
| 2024-03-31 | $14.89 Million | $-5.94 Million | -0.399x | +6.40% |
| 2023-03-31 | $30.38 Million | $-12.96 Million | -0.426x | -77.25% |
| 2022-03-31 | $33.21 Million | $-7.99 Million | -0.241x | -268.14% |
| 2021-03-31 | $27.46 Million | $-1.79 Million | -0.065x | -23.88% |
| 2020-03-31 | $25.71 Million | $-1.36 Million | -0.053x | -10.97% |
| 2019-03-31 | $24.90 Million | $-1.18 Million | -0.048x | -4.95% |
| 2018-03-31 | $22.07 Million | $-999.86K | -0.045x | +39.83% |
| 2017-03-31 | $22.71 Million | $-1.71 Million | -0.075x | +3.96% |
| 2016-03-31 | $21.45 Million | $-1.68 Million | -0.078x | -28.41% |
| 2015-03-31 | $20.42 Million | $-1.25 Million | -0.061x | +46.21% |
| 2014-03-31 | $21.02 Million | $-2.39 Million | -0.113x | -13.81% |
| 2013-03-31 | $16.45 Million | $-1.64 Million | -0.100x | +22.61% |
| 2012-03-31 | $10.23 Million | $-1.32 Million | -0.129x | -32.33% |
| 2011-03-31 | $11.14 Million | $-1.08 Million | -0.097x | -684.51% |
| 2010-03-31 | $3.04 Million | $-37.74K | -0.012x | -- |
About ZEN Graphene Solutions Ltd
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also… Read more